☆ 4.3 Editorial Material

Paving the way to an antivirulence strategy against fungal pathogens: lessons learned from Candida albicans

FUTURE MICROBIOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Biotechnology & Applied Microbiology

Anti-virulence activity of novel (1-heteroaryloxy-2-hydroxypropyl)- phenylpiperazine derivatives against both wild-type and clinical drug-resistant Candida albicans strains

Junjun Huang et al.

Summary: A new class of phenylpiperazine compounds with strong inhibitory activity against Candida albicans has been discovered. These compounds can reduce the virulence of C. albicans strains, including drug-resistant ones, and improve the composition of the gut microbiota in infected mice.

MICROBIAL BIOTECHNOLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Recent Advances of Marine Natural Indole Products in Chemical and Biological Aspects

Haoyi Sun et al.

Summary: The ocean is an important source of natural products, and in recent years, researchers have made significant progress in the fields of separation and extraction, derivative synthesis, structural studies, and biological evaluation of marine natural products. This review focuses on marine indole natural products with good pharmacological activity and research value, including monomeric indoles, indole peptides, bis-indoles, and annelated indoles. Most of these compounds exhibit cytotoxic, antiviral, antifungal, or anti-inflammatory activities.

MOLECULES (2023)

Add to Collection

Review Medical Laboratory Technology

Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance

Nathan P. Wiederhold

Summary: This article introduces the importance of emerging fungal infections, antifungal resistance, and fungal co-infections with respiratory pathogens. These infections are challenging for both clinicians and laboratory personnel, and may lead to poor clinical outcomes.

CLINICAL CHEMISTRY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Emerging Antifungal Targets and Strategies

Marija Ivanov et al.

Summary: Despite extensive research on antifungal drug discovery, fungal infections continue to pose a significant healthcare burden. The current antifungal options are limited in their efficacy and safety, calling for the development of novel antifungals. As our understanding of fungal physiology and infection mechanisms advances, there is an opportunity to utilize this knowledge for the development of new generations of antifungals.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Marine Based Natural Products: Exploring the Recent Developments in the Identification of Antimicrobial Agents

Ajay M. S. Krishna et al.

Summary: This review covers nearly 200 marine-based antimicrobial agents discovered from 2010 to 2022. These compounds, belonging to 11 structural classes, have exhibited medium to high antimicrobial activity against various microorganisms.

CHEMISTRY & BIODIVERSITY (2022)

Add to Collection

Review Pharmacology & Pharmacy

Review on Plant-Based Management in Combating Antimicrobial Resistance-Mechanistic Perspective

Masita Arip et al.

Summary: Antimicrobial resistance is a significant global health problem that requires multilevel attention and global cooperation. Plant metabolites have been widely studied for their antibacterial, antiviral, antifungal, and antiparasitic effects, and they work synergistically with conventional antibiotics to enhance antimicrobial effects.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Instruments & Instrumentation

Polymeric micelles with anti-virulence activity against Candida albicans in a single- and dual-species biofilm

Yassamin N. Albayaty et al.

Summary: Polymeric micelles composed of specific polymers showed inhibitory effects on fungal biofilms and effectively removed existing biofilms. Co-delivery of fluconazole and amphotericin B with micelles exhibited synergistic effects against Candida biofilms, indicating potential for combating fungal resistance.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)

Add to Collection

Article Mycology

Antivirulence activity and in vivo efficacy of a thiazole derivative against candidiasis

Nivea Pereira de Sa et al.

Summary: The synthesized compound MT showed antifungal activity against Candida albicans both in vitro and in vivo, with the ability to inhibit virulence factors. MT was able to decrease the expression of C. albicans genes involved in biofilm formation and morphogenesis, and showed potential therapeutic activity in a murine model of oral candidiasis. The results suggest that MT is a promising antivirulence compound for candidiasis therapy, especially for topical use.

JOURNAL DE MYCOLOGIE MEDICALE (2021)

Add to Collection

Article Microbiology

Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans-In Silico, In Vitro and In Vivo Approaches

Andre L. S. Santos et al.

Summary: The study found that lopinavir exhibits antifungal effects by inhibiting the aspartic proteases (Saps) of Candida albicans, leading to growth inhibition and irreversible morphological changes in the fungus.

JOURNAL OF FUNGI (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Virulence Factors in Candida species

Monika Staniszewska

CURRENT PROTEIN & PEPTIDE SCIENCE (2020)

Add to Collection

Article Microbiology

5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans

Ganapathy Ashwinkumar Subramenium et al.

MICROBIOLOGICAL RESEARCH (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

Efficacy of 7-benzyloxyindole and other halogenated indoles to inhibit Candida albicans biofilm and hyphal formation

Ranjith Kumar Manoharan et al.

MICROBIAL BIOTECHNOLOGY (2018)

Add to Collection

Article Immunology

Antibiofilm and Antivirulence Activities of 6-Gingerol and 6-Shogaol Against Candida albicans Due to Hyphal Inhibition

Jin-Hyung Lee et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)

Add to Collection

Article Microbiology

Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation

Jesus A. Romo et al.

MBIO (2017)

Add to Collection

Article Pharmacology & Pharmacy

Obiltoxaximab: First Global Approval

Sarah L. Greig

DRUGS (2016)

Add to Collection

Article Immunology

Overview: Global and Local Impact of Antibiotic Resistance

Richard R. Watkins et al.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)

Add to Collection

Article Microbiology

Approval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration Animal Rule

Chia-Wei Tsai et al.

FRONTIERS IN MICROBIOLOGY (2015)

Add to Collection

Review Pharmacology & Pharmacy

Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs

Christopher G. Pierce et al.

EXPERT OPINION ON DRUG DISCOVERY (2013)

Add to Collection

Article Pharmacology & Pharmacy

Lopinavir/Ritonavir A Review of its Use in the Management of HIV-1 Infection

Jamie D. Croxtall et al.

DRUGS (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.